Charles River Laboratories International (CRL) Net Cash Flow (2016 - 2025)
Charles River Laboratories International has reported Net Cash Flow over the past 17 years, most recently at $2.8 million for Q4 2025.
- Quarterly results put Net Cash Flow at $2.8 million for Q4 2025, down 61.39% from a year ago — trailing twelve months through Dec 2025 was -$8.4 million (up 86.33% YoY), and the annual figure for FY2025 was -$8.4 million, up 86.33%.
- Net Cash Flow for Q4 2025 was $2.8 million at Charles River Laboratories International, down from $27.5 million in the prior quarter.
- Over the last five years, Net Cash Flow for CRL hit a ceiling of $227.0 million in Q1 2021 and a floor of -$249.6 million in Q2 2021.
- Median Net Cash Flow over the past 5 years was $1.4 million (2023), compared with a mean of -$3.5 million.
- Biggest five-year swings in Net Cash Flow: soared 311.29% in 2021 and later plummeted 314771.43% in 2024.
- Charles River Laboratories International's Net Cash Flow stood at $19.6 million in 2021, then soared by 54.06% to $30.2 million in 2022, then soared by 251.64% to $106.1 million in 2023, then crashed by 93.05% to $7.4 million in 2024, then tumbled by 61.39% to $2.8 million in 2025.
- The last three reported values for Net Cash Flow were $2.8 million (Q4 2025), $27.5 million (Q3 2025), and -$59.7 million (Q2 2025) per Business Quant data.